Session Learning Objectives:
1. Understand current national guidelines of urine toxicology testing;
2. Recognize how the lived experiences of birthing people can be adversely shaped by substance use testing;
3. Recognize how structural racism has shaped the welfare system and the criminalization of substance use in pregnancy;
4. Understand the downstream implications of urine toxicology testing on families;
5. Identify evidence-based practices for screening substance use during the perinatal period.
Cecily Barber, MD, MPH (Addiction Medicine Fellow)
David Gootenberg, MD, PhD (BCRP, PGY-2)
Alex Pottorff, MD, MPH (BCRP, PGY-3)
Rohan Khazanchi, MD, MPH (BCRP, Med-Peds, PGY-1)
The presenters has no relevant financial relationships to disclose.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation